Psychosis with Huntington's disease: Role of antipsychotic medications

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Ding, Jonathan ^a   Gadit, Amin Muhammad ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CEFALEXIN; CITALOPRAM; RISPERIDONE; TIOTROPIUM BROMIDE;

ADULT; AGGRESSION; AGITATION; ARTICLE; CASE REPORT; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; FAMILY HISTORY; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; LOW DRUG DOSE; MALE; MIDDLE AGED; PERSEVERATION; PERSONALITY DISORDER; PNEUMONIA; PRIORITY JOURNAL; PSYCHOSIS; SEPARATED PERSON; UNEMPLOYMENT; VERBAL HOSTILITY;

EID: 84907342703     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-202625     Document Type: Article

References (14)

1. Pringsheim T, Wiltshire K, Day L, et al. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord 2012;27:1083-91.
2. Van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007 (Fall);19:441-8. (Pubitemid 350156103)
3. Nagel M, Rumpf HJ, Kasten M. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis. Gen Hosp Psychiatry 2014;36:361.e3-4.
4. Van Duijn E, Kingma EM, Timman R, et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington' s disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 2008;69:1804-10.
5. Rosenbaum D. Psychosis with Huntington's chorea. Psychiatr Q 1941;15:93-9.
6. Singer C. Comprehensive treatment of Huntington disease and other choreic disorders. Cleve Clin J Med 2012;79:(Suppl 2):S30-4.
7. Paulsen JS, Ready RE, Hamilton JM, et al. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 2001;71:310-14. (Pubitemid 32772526)
8. Reedeker W, van der Mast RC, Giltay EJ, et al. Psychiatric disorders in Huntington's disease: a 2-year follow-up study. Psychosomatics 2012;53:220-9.
9. Duff K, Beglinger LJ, O'Rourke ME, et al. Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease. Ann Clin Psychiatry 2008;20:1-3. (Pubitemid 351302395)
10. Madhusoodanan S, Brenner R, Moise D, et al. Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study. Ann Clin Psychiatry 1998;10:117-20. (Pubitemid 28495146)
11. Erdemoglu AK, Boratav C. Risperidone in chorea and psychosis of Huntington's disease. Eur J Neurol 2002;9:182-3. (Pubitemid 35021260)
12. Cankurtaran ES, Ozalp E, Soygur H, et al. A Clinical experience with risperidone and memantine in the treatment of Huntington's disease. J Natl Med Assoc 2006;98:1353-5. (Pubitemid 44167763)
13. Lin W, Chou Y. Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease. Am J Psychiatry 2008;165:1207-8.
14. Alpay M, Koroshetz WJ. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease. Psychosomatics 2006;47:70-2. (Pubitemid 43017124)